Cerebral small vessel disease
Citation, DOI and article data
Cerebral small vessel disease (alternatively subcortical small vessel disease, chronic small vessel disease, or cerebral microangiopathy) is an umbrella term for lesions in the subcortical brain attributed to pathologic changes in the small vessels. It is the most common cause of vascular dementia/cognitive impairment and is a major cause of ischemic and hemorrhagic strokes.
There is wide variability in the literature regarding terminology for small vessel disease.
With respect to anatomy, small vessels include arterioles, capillaries, and small veins/venules. The arterial bed has been a primary focus of the literature, with arterial small vessel disease being a proposed term for this entity, but venous collagenosis is also responsible for some of the changes 15. The small vessels involved are too small to visualize by imaging, so imaging focuses on their sequelae.
With respect to morphologic changes visible on imaging, small vessel disease includes small subcortical (lacunar) infarcts (of deep gray nuclei and deep white matter), hemorrhages, perivascular spaces, and diffuse white matter changes 14,16. The latter has received much attention in particular and is the focus of this article. Analogous signal changes in the subcortical gray matter and brainstem are typically excluded from discussion unless explicitly stated, leading to terms that focus on small vessel disease of white matter 16.
The term leukoaraiosis is a radiological descriptor applied to white matter hypodensities on CT and high signal changes on T2-weighted MRI of presumed vascular origin 14,16. These lesions are also called white matter lesions, white matter hyperintensities (for MRI), or white matter changes 16. Similar terms focused on the white matter include white matter disease, white matter damage, and leukoencephalopathy (the latter usually used in the context of CADASIL) 16. Less commonly, the lesions are called unidentified bright objects on MRI, but this term has also confusingly been used to refer to the focal areas of signal intensity in brains of children with neurofibromatosis type 1, which is an unrelated process.
Many etiopathogenic types of small vessel disease are described (see below). The most common is arteriolosclerosis, or age and vascular risk factor related small vessel disease, which based on a progressive clinical syndrome of cognitive impairment and compatible imaging features is diagnosed as Binswanger disease 14, although this term has fallen in popularity. Many variant terms for this entity presume an age-related etiology, such as age-related white matter hyperintensities/changes/disease/damage 16, although noting that not all age-related white matter changes are attributed to small vessel disease 14.
The nature of infarcts and white matter changes are primarily ischemic, so other terms used include small vessel chronic ischemia, microvascular ischemia, ischemic microangiopathy, and variants of the above terms such as ischemic white matter disease. However, hemorrhagic manifestations of small vessel disease (cerebral microbleeds, intracerebral hemorrhage, and superficial cortical siderosis) are also important to consider for differential diagnosis and therapeutic reasons 15,16.
Chronic small vessel disease is more common with increasing age. The prevalence of white matter lesions in the general population is reported to be between 39 to 96% 11.
Chronic small vessel disease is often an incidental asymptomatic finding on imaging. However, it has been shown to cause vascular dementia and it is more common in patients with dementia (vascular dementia, Alzheimer disease, Lewy body dementia) compared to the general population (100% v. 92% respectively in one study) 11,12.
There are several etiopathogenic types of cerebral small vessel diseases 15:
- arteriolosclerosis (age-related and vascular risk factor-related small vessel disease): see Binswanger disease
- cerebral amyloid angiopathy (sporadic or hereditary)
- inherited/genetic small vessel diseases other than cerebral amyloid angiopathy, such as
- inflammatory and immunologically medicated small vessel diseases (CNS vasculitis)
- venous collagenosis
- other small vessel diseases, such as
- post-radiation angiopathy
- non-amyloid microvessel degeneration in Alzheimer disease
Histology from these lesions show atrophy of axons and decreased myelin. The pathophysiology of white matter lesions is different depending on the area of involvement, i.e. periventricular or deep (subcortical) white matter. This difference is emphasized in the Fazekas scale in which the two are separated. Pathogenesis and especially its clinical significance are still incompletely understood 3,5.
Periventricular white matter lesions
Periventricular white matter changes (3-13 mm from the ventricular surface) are thought to be haemodynamically determined rather than only related to small vessel disease 8. This region is a vascular border zone vascularized by non-collateralising ventriculofugal vessels arising from subependymal arteries. As such, it is prone to local and systemic decrease in cerebral blood flow. It is a predictor of watershed infarcts especially when located along the posterior horns and it is correlated with carotid artery stenosis 8.
It is worth noting that juxtaventricular white matter changes (<3 mm from the ventricular surface), such as ependymitis granularis, are not related to small vessel disease, but rather represent cerebrospinal fluid leak due to disruption of the ependyma 10.
Deep and subcortical white matter lesions
Deep white matter changes (>13 mm from the ventricular surface, <4 mm from the corticomedullary junction) are thought to be caused by lipohyalinosis (small vessel disease), i.e. incomplete arteriosclerosis 8,9. They are a predictor of lacunar infarcts.
Chronic small vessel disease consists of bilateral patchy or diffuse white matter changes often observed on imaging studies 6,7. The Fazekas scale has been proposed to quantify white matter lesions related to leukoaraiosis. This is especially useful in the setting of dementia.
- non-enhancing white matter hypodensities
- T1: hypointense or isointense, less conspicuous than on T2/FLAIR
- T2/FLAIR: hyperintense
- DWI: no diffusion restriction
- T1 C+ (Gd): non-enhancing
History and etymology
The term leukoaraiosis means white matter rarefaction and comes from the Greek (leuko = white and araios = rarefaction). It was first proposed by Vladimir Hachinski (fl. 2021) a Ukrainian-born Canadian neurologist. He also coined the term multi-infarct dementia and developed the Hachinski ischemic scale 6,13.
The differential causes of small vessel disease are enumerated above in the Etiology section.
- 1. Amar K, Bucks RS, Lewis T et-al. The effect of white matter low attenuation on cognitive performance in dementia of the Alzheimer type. Age Ageing. 1996;25 (6): 443-8. doi:10.1093/ageing/25.6.443 - Pubmed citation
- 2. Amar K, Lewis T, Wilcock G et-al. The relationship between white matter low attenuation on brain CT and vascular risk factors: a memory clinic study. Age Ageing. 1995;24 (5): 411-5. Age Ageing (link) - Pubmed citation
- 3. Helenius J, Soinne L, Salonen O et-al. Leukoaraiosis, ischemic stroke, and normal white matter on diffusion-weighted MRI. Stroke. 2002;33 (1): 45-50. doi:10.1161/hs0102.101228 - Pubmed citation
- 4. Pantoni L, Garcia JH. Pathogenesis of leukoaraiosis: a review. Stroke. 1997;28 (3): 652-9. doi:10.1161/01.STR.28.3.652 - Pubmed citation
- 5. Geerlings MI, Appelman AP, Vincken KL et-al. Association of white matter lesions and lacunar infarcts with executive functioning: the SMART-MR study. Am. J. Epidemiol. 2009;170 (9): 1147-55. doi:10.1093/aje/kwp256 - Pubmed citation
- 6. Hachinski VC, Potter P, Merskey H. Leuko-araiosis: an ancient term for a new problem. Can J Neurol Sci. 1987;13 (4 Suppl): 533-4. Pubmed citation
- 7. Grueter BE, Schulz UG. Age-related cerebral white matter disease (leukoaraiosis): a review. Postgraduate medical journal. 88 (1036): 79-87. doi:10.1136/postgradmedj-2011-130307 - Pubmed
- 8. Kim KW, MacFall JR, Payne ME. Classification of white matter lesions on magnetic resonance imaging in elderly persons. (2008) Biological psychiatry. 64 (4): 273-80. doi:10.1016/j.biopsych.2008.03.024 - Pubmed
- 9. Xiong, Yun Yun, Mok, Vincent. Age-Related White Matter Changes. (2018) Journal of Aging Research. 2011: 617927. doi:10.4061/2011/617927 - Pubmed
- 10. Franz Fazekas, Reinhold Schmidt, Philip Scheltens. Pathophysiologic Mechanisms in the Development of Age-Related White Matter Changes of the Brain. (1998) Dementia and Geriatric Cognitive Disorders. 9 (Suppl. 1): 2. doi:10.1159/000051182 - Pubmed
- 11. Prins ND, Scheltens P. White matter hyperintensities, cognitive impairment and dementia: an update. (2015) Nature reviews. Neurology. 11 (3): 157-65. doi:10.1038/nrneurol.2015.10 - Pubmed
- 12. Lee SJ, Kim JS, Lee KS, An JY, Kim W, Kim YI, Kim BS, Jung SL. The leukoaraiosis is more prevalent in the large artery atherosclerosis stroke subtype among Korean patients with ischemic stroke. (2008) BMC neurology. 8: 31. doi:10.1186/1471-2377-8-31 - Pubmed
- 13. Goodman A. Vladimir Hachinski: a pioneer in the field of stroke. (2009) The Lancet. Neurology. 8 (1): 34. doi:10.1016/S1474-4422(08)70285-0 - Pubmed
- 14. Rosenberg GA, Wallin A, Wardlaw JM, Markus HS, Montaner J, Wolfson L, Iadecola C, Zlokovic BV, Joutel A, Dichgans M, Duering M, Schmidt R, Korczyn AD, Grinberg LT, Chui HC, Hachinski V. Consensus statement for diagnosis of subcortical small vessel disease. (2016) Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism. 36 (1): 6-25. doi:10.1038/jcbfm.2015.172 - Pubmed
- 15. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. (2010) The Lancet. Neurology. 9 (7): 689-701. doi:10.1016/S1474-4422(10)70104-6 - Pubmed
- 16. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Lindley RI, O'Brien JT, Barkhof F, Benavente OR, Black SE, Brayne C, Breteler M, Chabriat H, Decarli C, de Leeuw FE, Doubal F, Duering M, Fox NC, Greenberg S, Hachinski V, Kilimann I, Mok V, Oostenbrugge Rv, Pantoni L, Speck O, Stephan BC, Teipel S, Viswanathan A, Werring D, Chen C, Smith C, van Buchem M, Norrving B, Gorelick PB, Dichgans M. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. (2013) The Lancet. Neurology. 12 (8): 822-38. doi:10.1016/S1474-4422(13)70124-8 - Pubmed